Amphastar Pharmaceuticals

AMPHNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.041 B

$24.48 +3.64%

Close of 21 Sept 2026

Revenue

$719.9M

#1721 by revenue

Earnings

$98.1M

#1322 by earnings

Shares outstanding

42,537,944

Latest filing cover page

P/E ratio

10.6

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#152Jade BiosciencesJBIO$1.06B
#153Corvus PharmaceuticalsCRVS$1.04B
#154Amphastar PharmaceuticalsAMPH$1.04B
#155Janux TherapeuticsJANX$1.04B
#156Kura OncologyKURA$1.03B

What if Amphastar Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $30.3T

$711,695.28

Per share 29,073× higher

Bitcoin $1.72T

$40,429.87

Per share 1,652× higher

Nvidia $5.48T

$128,822.82

Per share 5,262× higher

Or at a round number

$2.00B $5.00B $10.0B $20.0B

Where these numbers come from

Share counts and financials for Amphastar Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.